Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Cash from Operations (2020 - 2025)

Historic Cash from Operations for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to -$15.2 million.

  • Maravai Lifesciences Holdings' Cash from Operations fell 21533.19% to -$15.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$49.4 million, marking a year-over-year decrease of 26539.99%. This contributed to the annual value of $7.5 million for FY2024, which is 9408.59% down from last year.
  • Maravai Lifesciences Holdings' Cash from Operations amounted to -$15.2 million in Q3 2025, which was down 21533.19% from -$10.3 million recorded in Q2 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Cash from Operations peaked at $165.9 million during Q2 2021, and registered a low of -$15.2 million during Q3 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' median Cash from Operations value was $19.2 million (recorded in 2023), while the average stood at $52.8 million.
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Cash from Operations surged by 132866.12% in 2021, and later tumbled by 28790.76% in 2024.
  • Maravai Lifesciences Holdings' Cash from Operations (Quarter) stood at $58.7 million in 2021, then surged by 69.1% to $99.3 million in 2022, then crashed by 92.16% to $7.8 million in 2023, then tumbled by 287.91% to -$14.6 million in 2024, then fell by 3.5% to -$15.2 million in 2025.
  • Its last three reported values are -$15.2 million in Q3 2025, -$10.3 million for Q2 2025, and -$9.4 million during Q1 2025.